TrialJournal of diabetes investigation2019

Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study.

Takashi Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.